PRCT — Procept Biorobotics Cashflow Statement
0.000.00%
- $3.14bn
- $2.97bn
- $136.19m
- 31
- 11
- 84
- 37
Annual cashflow statement for Procept Biorobotics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -42 | -53 | -59.9 | -87.2 | -106 |
Depreciation | |||||
Non-Cash Items | 0.195 | 2.3 | 3.9 | 15.4 | 20.2 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -3.53 | -0.483 | -4.71 | -11.5 | -26.2 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -43.8 | -48.3 | -57.3 | -80.4 | -108 |
Capital Expenditures | -7.61 | -0.233 | -0.592 | -2.65 | -25.2 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 50.8 | 0 | — | — | — |
Sale/Maturity of Investment | |||||
Cash from Investing Activities | 43.2 | -0.233 | -0.592 | -2.65 | -25.2 |
Financing Cash Flow Items | — | — | — | -4 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 26.5 | 107 | 262 | 3.61 | 168 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 25.9 | 58.2 | 204 | -79.4 | 34.6 |